Search

Robert C. Boyle

Examiner (ID: 9565, Phone: (571)270-7347 , Office: P/1764 )

Most Active Art Unit
1764
Art Unit(s)
1764, 1796
Total Applications
1334
Issued Applications
896
Pending Applications
89
Abandoned Applications
374

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5028059 [patent_doc_number] => 20070269506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Oral Sustained Release Pharmaceutical Composition' [patent_app_type] => utility [patent_app_number] => 10/556641 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 3661 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269506.pdf [firstpage_image] =>[orig_patent_app_number] => 10556641 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/556641
Oral sustained release pharmaceutical composition May 18, 2004 Issued
Array ( [id] => 4970806 [patent_doc_number] => 20070110808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Extended release osmo-microsealed formulation' [patent_app_type] => utility [patent_app_number] => 10/563631 [patent_app_country] => US [patent_app_date] => 2004-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5386 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20070110808.pdf [firstpage_image] =>[orig_patent_app_number] => 10563631 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/563631
Extended release osmo-microsealed formulation May 13, 2004 Abandoned
Array ( [id] => 5699662 [patent_doc_number] => 20060216346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Dosage form containing (s)-pantoprazole as active ingredient' [patent_app_type] => utility [patent_app_number] => 10/555331 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10203 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216346.pdf [firstpage_image] =>[orig_patent_app_number] => 10555331 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/555331
Dosage form containing (s)-pantoprazole as active ingredient May 6, 2004 Abandoned
Array ( [id] => 5921593 [patent_doc_number] => 20060240100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Dosage form containing pantoprazole as active ingredient' [patent_app_type] => utility [patent_app_number] => 10/555238 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10303 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240100.pdf [firstpage_image] =>[orig_patent_app_number] => 10555238 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/555238
Dosage form containing pantoprazole as active ingredient May 6, 2004 Abandoned
Array ( [id] => 5887475 [patent_doc_number] => 20060275235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Cation-modified galactomannan polysaccharide and cosmetic composition containing the same' [patent_app_type] => utility [patent_app_number] => 10/554874 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17785 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275235.pdf [firstpage_image] =>[orig_patent_app_number] => 10554874 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/554874
Cation-modified galactomannan polysaccharide and cosmetic composition containing the same May 6, 2004 Abandoned
Array ( [id] => 5074876 [patent_doc_number] => 20070014851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts' [patent_app_type] => utility [patent_app_number] => 10/555354 [patent_app_country] => US [patent_app_date] => 2004-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3060 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20070014851.pdf [firstpage_image] =>[orig_patent_app_number] => 10555354 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/555354
Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts May 2, 2004 Issued
Array ( [id] => 4999409 [patent_doc_number] => 20070042043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Pellet formulations of acid-labile benzimidazonle compounds' [patent_app_type] => utility [patent_app_number] => 10/554727 [patent_app_country] => US [patent_app_date] => 2004-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3332 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20070042043.pdf [firstpage_image] =>[orig_patent_app_number] => 10554727 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/554727
Pellet formulations of acid-labile benzimidazonle compounds Apr 26, 2004 Abandoned
Array ( [id] => 6966075 [patent_doc_number] => 20050232972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Drug delivery via punctal plug' [patent_app_type] => utility [patent_app_number] => 10/825047 [patent_app_country] => US [patent_app_date] => 2004-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1379 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232972.pdf [firstpage_image] =>[orig_patent_app_number] => 10825047 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/825047
Drug delivery via punctal plug Apr 14, 2004 Abandoned
Array ( [id] => 7347581 [patent_doc_number] => 20040192763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'NMDA NR2B antagonists for treatment' [patent_app_type] => new [patent_app_number] => 10/821526 [patent_app_country] => US [patent_app_date] => 2004-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9778 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192763.pdf [firstpage_image] =>[orig_patent_app_number] => 10821526 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/821526
NMDA NR2B antagonists for treatment Apr 8, 2004 Abandoned
Array ( [id] => 7346908 [patent_doc_number] => 20040192660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Protocol for improving vision' [patent_app_type] => new [patent_app_number] => 10/820264 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1561 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192660.pdf [firstpage_image] =>[orig_patent_app_number] => 10820264 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/820264
Protocol for improving vision Apr 7, 2004 Abandoned
Array ( [id] => 7018854 [patent_doc_number] => 20050220873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist' [patent_app_type] => utility [patent_app_number] => 10/815926 [patent_app_country] => US [patent_app_date] => 2004-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11563 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20050220873.pdf [firstpage_image] =>[orig_patent_app_number] => 10815926 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/815926
Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist Apr 1, 2004 Abandoned
Array ( [id] => 7018723 [patent_doc_number] => 20050220742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Compositions and methods for maintaining eyelid hygiene' [patent_app_type] => utility [patent_app_number] => 10/816513 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6048 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20050220742.pdf [firstpage_image] =>[orig_patent_app_number] => 10816513 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/816513
Compositions and methods for maintaining eyelid hygiene Mar 30, 2004 Abandoned
Array ( [id] => 5807312 [patent_doc_number] => 20060093666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Formulations for tyrosine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/544213 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4039 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20060093666.pdf [firstpage_image] =>[orig_patent_app_number] => 10544213 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/544213
Formulations for tyrosine kinase inhibitors Mar 22, 2004 Abandoned
Array ( [id] => 4651106 [patent_doc_number] => 20080038362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Composition For An Enteric Coating Of Natural Product Containing Lectin' [patent_app_type] => utility [patent_app_number] => 10/559988 [patent_app_country] => US [patent_app_date] => 2004-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6918 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20080038362.pdf [firstpage_image] =>[orig_patent_app_number] => 10559988 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/559988
Composition For An Enteric Coating Of Natural Product Containing Lectin Mar 18, 2004 Abandoned
Array ( [id] => 5694805 [patent_doc_number] => 20060154952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation-and ummunologically-mediated diseases' [patent_app_type] => utility [patent_app_number] => 10/547185 [patent_app_country] => US [patent_app_date] => 2004-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7321 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154952.pdf [firstpage_image] =>[orig_patent_app_number] => 10547185 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/547185
Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation-and ummunologically-mediated diseases Mar 15, 2004 Abandoned
Array ( [id] => 7316840 [patent_doc_number] => 20040224017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Process for preparing sustained release tablets' [patent_app_type] => new [patent_app_number] => 10/800984 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9024 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224017.pdf [firstpage_image] =>[orig_patent_app_number] => 10800984 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/800984
Process for preparing sustained release tablets Mar 14, 2004 Abandoned
Array ( [id] => 7345839 [patent_doc_number] => 20040247674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Drug delivery system' [patent_app_type] => new [patent_app_number] => 10/487992 [patent_app_country] => US [patent_app_date] => 2004-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7760 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20040247674.pdf [firstpage_image] =>[orig_patent_app_number] => 10487992 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/487992
Drug delivery system Mar 11, 2004 Abandoned
Array ( [id] => 5595830 [patent_doc_number] => 20060159746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Compositions comprising fatty acids and amino acids' [patent_app_type] => utility [patent_app_number] => 10/546942 [patent_app_country] => US [patent_app_date] => 2004-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11185 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20060159746.pdf [firstpage_image] =>[orig_patent_app_number] => 10546942 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/546942
Compositions comprising fatty acids and amino acids Feb 22, 2004 Abandoned
Array ( [id] => 5687854 [patent_doc_number] => 20060286169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Lipophilic compositions' [patent_app_type] => utility [patent_app_number] => 10/545416 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3813 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20060286169.pdf [firstpage_image] =>[orig_patent_app_number] => 10545416 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/545416
Lipophilic compositions Feb 12, 2004 Abandoned
Array ( [id] => 5595732 [patent_doc_number] => 20060159648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Novel therapeutic method and compositions for topical administration' [patent_app_type] => utility [patent_app_number] => 10/545773 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13720 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20060159648.pdf [firstpage_image] =>[orig_patent_app_number] => 10545773 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/545773
Novel therapeutic method and compositions for topical administration Feb 12, 2004 Abandoned
Menu